Product Images Adcetris

This is a drug information label for the drug 'brentuximab vedotin'. It is a 50mg/vial single-dose injection for intravenous use only. The label provides directions for reconstitution and dilution of the drug and includes recommended dosage and storage information. The label also includes the drug's manufacturer, Seagen, and contact information for more information.*

This is a description for B-Rentuximab Vedotin, an injectable drug with a strength of 50mg/vial, intended for intravenous use only. The drug is stored in a single-dose vial and requires reconstitution and dilution before administration. It is recommended to store the vial at 2°C to 8°C to protect it from light. The drug is manufactured by Seagen Inc., and its prescribing information contains details about dosage and dilution. The given text also includes the drug's NDC code, recommended storage, and manufacturer's license number. No further description is available.*

The text is a graph showing the Progression-Free Survival measured by the Kaplan Meier Curve of IRF-Assessed Progression-Free Survival from Study 6: ECHELON-2. The graph is comparing the ACHP group versus the CHOP group. The x-axis indicates the time from randomization in months, and the y-axis indicates the natural risk events. There are numbers and letters scattered throughout the graph, representing each group's details and results.*